Astor Pharmaceuticals LLC – Trademark Portfolio

Entity Type: 16

Astor Pharmaceuticals LLC holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ASTOR DRUGS. The owner is based in Holtsville, NY.

665 Union Ave, Suite 3

Holtsville, NY 11742

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Astor Pharmaceuticals LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Astor Pharmaceuticals LLC have?

Astor Pharmaceuticals LLC has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.

What trademark classes does Astor Pharmaceuticals LLC file in?

Astor Pharmaceuticals LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 5 (Pharmaceuticals). Class 35 covers advertising; business management; business administration; office functions.

What are Astor Pharmaceuticals LLC's most well-known trademarks?

Astor Pharmaceuticals LLC's registered trademark portfolio includes well-known marks such as ASTOR DRUGS. These are among 1 currently registered trademark in the portfolio.

What is Astor Pharmaceuticals LLC's trademark registration success rate?

Astor Pharmaceuticals LLC has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.